We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
292 result(s) found, displaying 51 to 60
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Australian public assessment report (AusPar)Aquipta (atogepant) has been approved for the prophylaxis of migraine in adults who have at least four migraine days per month
-
Prescription medicine registrationActive ingredients: foscarbidopa, foslevodopa.
-
-
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
GENOPTIC gentamicin 3mg/mL (as sulfate) eye drops bottle Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Abbvie Pty Ltd -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial.